Ultragenyx Pharmaceutical
RARE
RARE
174 hedge funds and large institutions have $2.93B invested in Ultragenyx Pharmaceutical in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 61 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 61
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less call options, than puts
Call options by funds: $6.29M | Put options by funds: $6.65M
Holders
174
Holding in Top 10
1
Calls
$6.29M
Puts
$6.65M
Top Buyers
| 1 | +$78.9M | |
| 2 | +$36.6M | |
| 3 | +$28.2M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$14.6M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$12.2M |
Top Sellers
| 1 | -$21.1M | |
| 2 | -$16.9M | |
| 3 | -$16.8M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$11.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11.1M |